![]() |
市場調查報告書
商品編碼
2050406
全球血管通路設備市場:市場規模、佔有率和趨勢分析(2026-2032 年)Access Device Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Trocar and Single-Port Access Devices |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2025年全球門禁設備市場規模略高於9.9億美元。預計該市場將以3.1%的年複合成長率成長,到2032年將超過12億美元。
這份綜合報告涵蓋了全球手術入路器械市場,包括一次性、可重複插入和可重複使用的套管針。報告也探討了全球腹腔鏡手術中使用的單孔入路器械。
該分析包括銷售量、平均售價 (ASP)、手術數量、市場規模、成長趨勢、市場促進因素和限制因素、到 2032 年的市場預測以及到 2022 年的歷史數據。它還涵蓋了近期併購、公司簡介、產品系列和主要參與者。
腹腔鏡手術數量的穩定成長以及對可靠手術入路產品的持續需求,是推動市場成長的主要因素。此外,無刀片、光學和整合式密封套管等先進入路設備的出現,也促進了已開發地區市場規模的擴大。
市場概覽
全球手術入路器械市場涵蓋用於在腹腔鏡手術中創建和維持穿刺傷口的各種產品。這些器械在微創手術中至關重要,因為它們使外科醫生能夠將內視鏡、器械和其他工具插入腹腔。
該市場包括套管針和單孔入路裝置。套管針仍然是主要產品類型,包括一次性、可重複插入和可重複使用型。單孔入路裝置輔助透過單一主切口進行的手術,用於特定的腹腔鏡手術。
手術入路裝置廣泛應用於一般外科、婦科、泌尿系統和其他腹腔鏡專科手術。其需求與手術數量、醫院採購趨勢以及腹腔鏡手術作為核心微創手術方式的持續發展密切相關。
預計成長將保持穩定而非快速。傳統腹腔鏡手術仍然是介入器械需求的主要驅動力,但機器人輔助手術正在改變某些手術中器械的使用方式。同時,一次性器械仍佔據主導地位,因為它們簡化了工作流程,減少了重複處理的需求,並使每次手術的成本可預測。
市場促進因素
腹腔鏡手術的數量仍然是全球手術入路器械市場的主要驅動力。腹腔鏡手術是應用最廣泛的微創手術技術之一,與開放性手術相比,它具有恢復更快、住院時間更短、術後併發症更少、手術風險更低等優點。隨著腹腔鏡手術在訓練中日益受到重視,可靠手術入路器械的需求仍然強勁。
一次性介入器械在消毒成本和工作流程效率方面也具有優勢。雖然可重複使用的套管針在每次使用成本上更具優勢,但許多醫療機構更傾向於使用一次性產品,因為它們可以減輕再處理負擔,並最大限度地減少交叉感染的風險。這一趨勢在新冠疫情期間更加明顯,並且至今仍是歐洲和北美地區的重要因素。
先進介入器材的引進也是推動市場成長的重要因素,尤其是在已開發市場。無刀片、光學和整合密封套管針便於插入,降低併發症風險,並支援與機器人輔助手術流程的兼容性。即使手術量成長緩慢,這些特性也能維持市場價值。
市場限制
再處理和第三方合約是限制一次性套管針銷量成長的因素。注重成本控制的醫院可能會利用製造商主導或第三方提供的再處理項目來延長可重複使用導管的使用壽命。雖然這些策略有助於預算管理,但也減少了對新型一次性產品的需求。
這種壓力在公共醫療體系和新興市場尤其突出,因為成本控制是採購決策中的重要因素。在這些環境下,可重複使用的產品和再處理策略仍然是相當吸引人的選擇,尤其是在手術量大而預算有限的情況下。
市場競爭也限制了價值成長。套管針市場競爭異常激烈,導致平均售價(ASP)面臨下行壓力。主要生產商在價格、合約期限和捆綁銷售等方面展開競爭,以贏得醫院和集團採購組織的訂單。來自亞太地區生產商的低成本一次性套管針也給歐洲和其他對價格敏感的地區帶來了價格壓力。
市場覆蓋範圍和數據範圍
本報告旨在幫助讀者評估在傳統腹腔鏡手術和機器人輔助手術的背景下,對一次性、可重複使用和可重複使用通路裝置的需求是如何變化的。
目標市場及區隔
套管針包括一次性、可重複使用和可重複使用的產品,這些產品貫穿整體腹腔鏡手術。
單孔入路裝置屬於更廣泛的入路裝置市場的一部分,用於特定的腹腔鏡手術工作流程。
每個細分市場都透過相關的定量指標進行分析,例如市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售量和平均售價。
競爭分析
2025年,Applied Medical在一次性醫療器材和介入器材市場佔據領先地位。其領先優勢主要得益於低成本、價格合理的一次性套管針,尤其是Kii®套管針平台。該平台廣泛應用於普通和專科腹腔鏡手術,使Applied Medical在對成本高度敏感、手術量大的醫療環境中佔據了有利地位。
Ethicon是全球介入器材市場第二大競爭對手。雖然該公司也提供混合型和可重複使用的套管針,但其主要業務是一次性產品,包括其ENDOPATH XCEL®套管針系列。 Ethicon通常將其產品定價高於市場平均水平,並依靠產品品質、品牌聲譽和外科醫生的熟悉度來促進銷售。
美敦力在血管通路器械市場佔有第三大市場。該公司憑藉其SILS™單端口血管通路器械在單端口血管通路器械領域競爭。美敦力也提供豐富的套管針產品,包括Versaport™、VersaOne™和VersaStep™等可重複使用套管針產品。此產品線能夠滿足醫院在一次性、可重複使用以及不同血管通路工作流程的多樣化需求。
科技和醫療治療的發展趨勢
一次性輸液裝置在許多醫療系統中仍然是主要產品類型。它們的吸引力在於每次使用成本可預測、庫存管理簡單以及再處理需求低。
無刀片套管針設計因其旨在減少穿刺過程中的組織損傷而持續受到關注。這些裝置可實現更安全的手術操作,並有助於降低腹腔鏡手術併發症的風險。
光學套管針在高階介入手術流程中也扮演著至關重要的角色。透過實現可視插入,這些設備能夠支援更精準的介入操作,並能增強臨床醫師在初始置入時的信心。
隨著醫院尋求能夠在手術過程中維持穩定的腹腔內壓力並減少滲漏的介入產品,整合密封套管的重要性日益凸顯。這些特性在更複雜或耗時更長的手術中尤其重要。
單孔入路仍屬於小眾領域。雖然它並未佔據入路器械需求的大部分,但在某些手術中,減少切口數量和優先考慮改善美容效果是關鍵考慮因素時,它就顯得非常有用。
機器人輔助手術也正在影響產品設計和購買行為。隨著醫院尋求能夠在傳統微創手術和機器人輔助手術流程中都適用的工具,對兼容機器人輔助手術的介入器械的需求可能會進一步成長。
地區
本報告涵蓋的全球調查區域包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。
目前全球門禁設備市場規模有多大?預計到 2032 年將如何成長?
套管針和單孔入路裝置在腹腔鏡手術的應用經驗如何?
隨著時間的推移,銷售量、平均售價、手術例數和市場規模發生了哪些變化?
為什麼許多醫療系統仍然偏愛一次性輸液裝置?
滅菌成本、工作流程效率以及對交叉污染的擔憂如何影響產品選擇?
再處理合約和可重複使用的介入裝置如何影響一次性套管針的需求?
市場競爭如何影響整個套管針細分市場的平均售價(ASP)?
醫療器材市場的主要參與者有哪些? Applied Medical、Ethicon 和 Medtronic 分別處於什麼位置?
iData Research 的《全球腹腔鏡手術器械市場報告》透過詳盡的市場規模、手術量分析、平均售價 (ASP) 趨勢、預測和競爭格局分析,解答了這些問題。該報告可用於評估全球腹腔鏡手術器械市場的需求、對標主要競爭對手、應對價格壓力並制定成長策略。
The global access device market was valued at just over $990 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 3.1%, reaching over $1.2 billion by 2032.
This comprehensive report covers the global market for access devices, including disposable, reposable and reusable trocars. It also includes single-port access devices used across laparoscopic procedures worldwide.
The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, growth trends, market drivers and limiters, market forecasts through 2032, and historical data back to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
Growth in this market is supported by steady laparoscopic procedure volumes and continued demand for reliable access products. Advanced access devices, including bladeless, optical and integrated sealing trocars, are also supporting market value expansion in developed regions.
Market Overview
The global access device market includes the products used to create and maintain entry points during laparoscopic surgery. These devices are critical to minimally invasive procedures because they allow surgeons to introduce scopes, instruments and other tools into the abdominal cavity.
The market includes trocars and single-port access devices. Trocars remain the primary product category and include disposable, reposable and reusable designs. Single-port access devices support procedures performed through one main incision and are used in selected laparoscopic applications.
Access devices are used across general surgery, gynecology, urology and other laparoscopic specialties. Their demand is closely tied to procedure volumes, hospital purchasing behavior and the continued role of laparoscopy as a core minimally invasive surgical approach.
Growth is expected to remain steady rather than rapid. Traditional laparoscopy continues to support demand for access devices, while robotic-assisted surgery reshapes product use in some procedures. At the same time, disposable products remain dominant because they simplify workflow, reduce reprocessing needs and provide predictable per-procedure costs.
Market Drivers
Laparoscopic procedure volume remains a major driver of the global access device market. Laparoscopy is one of the most widely used minimally invasive techniques and offers faster recovery, shorter hospital stays, fewer post-operative complications and reduced surgical risk compared to open surgery. As training continues to emphasize laparoscopic methods, demand for reliable access devices remains strong.
Disposable access devices are also supported by sterilization cost and workflow efficiency. While reusable trocars can offer per-use cost advantages, many healthcare systems prefer disposable products because they reduce reprocessing burden and help limit cross-contamination concerns. This trend became more pronounced during the COVID-19 period and has remained relevant in Europe and North America.
Advanced access device adoption is another driver, particularly in developed markets. Bladeless, optical and integrated sealing trocars can support easier insertion, reduced complication risk and compatibility with robotic-assisted workflows. These features help sustain market value even when overall procedure growth is moderate.
Market Limiters
Reprocessing and third-party contracts limit growth in disposable trocar volumes. Cost-conscious hospitals may use manufacturer-led or third-party reprocessing programs to extend the usable life of reusable access devices. These strategies help manage budgets but reduce incremental demand for new disposable products.
This pressure is especially important in public healthcare systems and emerging markets, where procurement decisions often focus heavily on cost containment. In these settings, reusable products and reprocessing strategies can remain attractive when procedure volumes are high and budgets are limited.
Market competition also limits value growth. The trocar market is highly competitive, which creates downward pressure on ASPs. Established manufacturers compete on pricing, contract length and bundled offerings to secure hospital and group purchasing organization contracts. Low-cost disposable trocars from Asia-Pacific manufacturers also pressure pricing in Europe and other cost-sensitive regions.
Market Coverage and Data Scope
The report is designed to help readers evaluate how disposable, reposable and reusable access device demand is changing across conventional laparoscopic and robotic-assisted surgical environments.
Markets Covered and Segmentation
Trocars include disposable, reposable and reusable products used across laparoscopic procedures.
Single-port access devices are included as part of the broader access device market and are used in selected laparoscopic workflows.
Each segment is analyzed through relevant quantitative measures, including market size, market shares, procedure numbers, market forecasts, market growth rates, units sold and average selling prices.
Competitive Analysis
Applied Medical led the disposable and overall access device market in 2025. The company's leadership is supported by its inexpensive and affordable disposable trocars, particularly the Kii(R) trocar platform. This platform is widely adopted across general and specialty laparoscopic procedures, giving Applied Medical a strong position in cost-sensitive and high-volume settings.
Ethicon was the second-leading competitor in the global access device market. Although the company offers hybrid and reposable trocars, it mainly specializes in disposable products, including its ENDOPATH XCEL(R) trocar portfolio. Ethicon generally prices its products at a premium above the market average and relies on product quality, brand reputation and surgeon familiarity to support sales.
Medtronic held the third position in the access device market. The company competes in the single-port access device segment through its SILS(TM) Access Port. Medtronic also offers a broad trocar portfolio, including Versaport(TM), VersaOne(TM) and VersaStep(TM) reposable trocar products. This range allows the company to serve multiple hospital preferences across disposable, reposable and access workflow needs.
Technology and Practice Trends
Disposable access devices remain the dominant product category in many healthcare systems. Their appeal comes from predictable per-procedure cost, simplified inventory management and reduced reprocessing requirements.
Bladeless trocar designs continue to gain attention because they are designed to reduce tissue trauma during entry. These devices may support safer access and help reduce complication concerns in laparoscopic procedures.
Optical trocars are also important in advanced access workflows. By allowing visual entry, these devices can support more controlled access and improve clinician confidence during initial placement.
Integrated sealing trocars are becoming more relevant as hospitals look for access products that support stable insufflation and reduce leakage during surgery. These features can be especially useful in more complex or longer procedures.
Single-port access remains a specialized category. While it does not represent the majority of access device demand, it supports selected procedures where fewer incisions and improved cosmetic outcomes are priorities.
Robotic-assisted surgery is also influencing product design and purchasing behavior. Access devices that are compatible with robotic-assisted procedures may see stronger demand as hospitals seek tools that work across conventional and robotic-assisted minimally invasive workflows.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
How large is the global access device market, and how is it expected to grow through 2032?
How are trocars and single-port access devices performing across global laparoscopic procedures?
How are unit sales, average selling prices, procedure numbers and market values changing over time?
Why do disposable access devices remain preferred in many healthcare systems?
How are sterilization costs, workflow efficiency and cross-contamination concerns shaping product selection?
What impact do reprocessing contracts and reusable access devices have on disposable trocar demand?
How is market competition affecting ASPs across the trocar segment?
Which companies lead the access device market, and how are Applied Medical, Ethicon and Medtronic positioned?
The Global Access Device Market Report from iData Research answers these questions with detailed market sizing, procedure number analysis, ASP trends, forecasts and competitive share insights. Use it to evaluate demand, benchmark leading competitors, assess pricing pressure and plan for growth across the global laparoscopic access device market.